Press "Enter" to skip to content

New patent expiration for Novartis drug EXFORGE


Annual Drug Patent Expirations for EXFORGE
Annual Drug Patent Expirations for EXFORGE

Exforge is a drug marketed by Novartis
and is included in two NDAs. It is available from three suppliers. There are four patents protecting this drug and six Paragraph IV challenges.

The generic ingredient in EXFORGE is amlodipine besylate; hydrochlorothiazide; valsartan. Three suppliers are listed for this compound. Additional details are available on the amlodipine besylate; hydrochlorothiazide; valsartan profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs,
or visit

Do NOT follow this link or you will be banned from the site!